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The homozygote Brattleboro rat exhibits a hereditary diabetes insipidus due to a deficiency of 
vasopressin, the antidiuretic hormone. It has previously been shown that in this animal a single 
nucleotide deletion in the provasopressin gene leads to a mutant precursor with a C-terminal amino 
acid sequence different from that of the wild-type. However the N-terminal region including the 
hol'mone moiety, the processing signal as well as the first two-thirds of the neurophysin is entirely 
preserved and absence of maturation has to be explained by an additional cause. We show here that 
the neurohypophysis of the homozygote Brattleboro rat, in contrast to the adenohypophysis, displays 
a significant decrease in the Lys-Arg processing endopeptidase activity when compared to the 
heterozygote or the wild-type Wistar. It is suggested that hypothalamic vasopressinergic neurons of 
the homozygote Brattleboro rat display a deficiency in the processing enzyme in contrast o the 
oxytocinergic neurons in which processing of prooxytocin s normal. 
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INTRODUCTION 
The Bat t leboro  rat is a mutant  form of the Long Evans strain displaying a 
heredi tary  d iabetes insipidus for the homozygote  phenotype  (d i /d i )  (1). The 
pathology is due to a lack of vasopressin product ion  and the subsequent  
deficiency of water  resorpt ion in the distal k idney tubuli  (2). Normal  rat 
vasopressin precursor  is a 147-residue prote in  compris ing three domains:  the 
hormone (residues 1 to 9) connected by a processing signal sequence G ly -Lys -Arg  
to MSEL-neurophys in  (res idues 13 to 105) itself fo l lowed by a second processing 
signal, an arginine and finally a g lycopept ide,  copept in  (residues 107 to 147) (ref. 
3-5) .  Compar ison  of the normal  rat provasopress in  gene (6) with the Brat t leboro  
gene (7) has revealed in the latter  a single base delet ion leading to a reading 
frame shift. As  a result the amino acid sequence of  the precursor  should change 
i Laboratory of Biological Chemistry, University of Paris VI 96, Boulevard Raspail, 75006 Paris 
(France). 
z To whom correspondence should be addressed 
445 
0144-8463/92/1200-0445506.50/0 ~) 1992 Plenum Publishing Corporation 
446 Chauvet, Rouille, Spang, Cardine and Acher 
from residue 76 up to the C-terminal. The N-terminal sequence including the 
hormonal moiety, the processing signal Gly-Lys-Arg and the first 2/3 of 
neurophysin is entirely preserved so that normal processing should occur 
provided that the precursor be actually expressed and able to follow the 
compartmental secretory pathway for meeting processing enzymes. Possible 
anomalies about these enzymes have therefore been searched for and a deficiency 
in Lys-Arg endoproteolytic activity has been detected in the homozygote 
Brattleboro rat. 
For explaining the lack of mature vasopressin several hypotheses have been 
proposed. Deficiency in the translation has first been suspected (8). However 
occurrence of a mutant provasopressin displaying immunoreactivity with an 
antibody raised against a synthetic 14-residue peptide derived from the predicted 
mutated region of the precursor has been shown (9, 10). Deficiency in the 
routage, the precursor remaining blocked in the membrane of the rough 
endoplasmic reticulum, has also been suggested (11). Possible variation in the 
conformation of the "pathological" precursor preventing the access of the 
processing endopeptidase has been discussed (12). Paradoxically mature vasopr- 
essin, identified by its immunological, physical and biological properties com- 
pared with those of synthetic vasopressin, has been found in the adrenal gland 
(13) and the ovary (14) of the homozygote Brattleboro rat. Futhermore, a few 
"solitary" hypothalmic neurons of this animal display all the immuno-reactivities 
of the wild-type vasopressin precursor (vasopressin, europhysin, copeptin) (14). 
Somatic intrachromosomal gene conversion between the homologous exons of the 
vasopressin and the related oxytocin genes generating the heterozygote di/+ 
phenotype has been proposed for explaining occurrence of the normal precursor 
in the solitary neurons (15). 
Another explanation for the provasopressin processing deficiency could be a 
default in the processing enzymes themselves either in their biosynthesis or in 
their action. Because neither vasopressinyl-Gly-Lys-Arg, nor vasopressinyl-Gly 
have been detected in the homozygote Brattleboro rat, the defect should affect 
the processing endopeptidase rather than carboxypeptidase E or the o~-amidating 
enzymes involved in the maturation. Calcium-dependent "dibasic" endopep- 
tidases have recently been studied in the secretory granules of neuroendocrine 
cells of human (17), ox, and rat (18). One type seems more specific for the pair 
Lys-Arg and the other type for the pair Arg-Arg; these enzymes are apparently 
devoid of monobasic endoproteolytic a tivity and have a pH optimum around 5.5 
(17, 18). 
We have examined comparatively the neurohypophysial secretory granules of 
the heterozygote and homozygote Brattleboro rats for their Lys-Arg en- 
doproteolytic activities using a fluorogenic synthetic substrate containing the 
dibasic sequence. 
MATERIALS AND METHODS 
Isolation of Neurosecretory Granules 
Heterozygote and homozygote Brattleboro rats of both sexes were kindly 
provided by Dr. L. Bankir (H6pital Necker, Paris) and Dr. A. Burlet (Lab. 
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d'Histologie, Nancy). These animals were 5-9 months old and their average 
weight was 240-370 g. Homozygotes urinated about 120 ml per day whereas 
heterozygotes gave one tenth of this volume. Parallel experiments were per- 
formed with normal Wistar rats (IFFA-Credo, L'Arbresle) in order to charac- 
terize the dibasic endopeptidases of the wild-type phenotype. 
Rats were killed by decapitation and anterior and posterior pituitary lobes 
were dissected out. The wet weight of the neurointermediate pituitary varied 
between 1.2 and 2.1 mg and the wet weight of the anterior pituitary between 7.5 
and 2.1 mg and the wet weight of the anterior pituitary between 7.5 and 10mg. 
Rat neurohypophysial granules were isolated as described previously (18-21). 
Tissues were homogenized in a potter Thomas AA in a 10 mM Tris-HC1 buffer 
pH 7.4 (50-100 #l/gland) containing 0.27 M sucrose and inhibitors: 1 mM EDTA, 
2.5 mM PMSF, 10/~M E64, 10/~M pepstatin, 50 ~uM TPCK, 50/~M TLCK, in 
order to block cytosol proteolytic enzymes. After a first centrifugation at 600 g 
(10 min, 4~ Sorvall centrifuge RC2B, rotor SS34), the supernatant was saved 
and the pellet was homogenized with fresh buffer and centrifuged under the same 
conditions. The combined supernatant (about 1 ml of 0.27 M sucrose) was layered 
on 1 ml of 0.6 M sucrose in a 3-ml tube. Centrifugation was carried out at 10.000 g 
for 1 h. Four phases could be distinguished: an upper layer (0.27 M sucrose), an 
interface, a lower layer and a pellet containing the most part of secretory 
granules. The granule yield at this stage, determined by comparing the neurophy- 
sin content of the recovered granules with the total amount, was roughly 
estimated about 50%. 
The pellet of secretory granules was suspended in 5 mM acetate buffer 
phi 5.5 (50 #l/gland) containing the inhibitors described above except EDTA and 
lysed by five freezing-thawing cycles. A first centrifugation (10.000 g, 30 rain, 4~ 
gave a supernatant and a pellet that was retreated under the same conditions. The 
combined supernatant is referred to as the granule content and the pellet 
suspended in the buffer (100/d/gland) as the granule membranes. 
HPLC Investigation of Granule Components 
15 ~1 from a total volume 500/~1 (9 neurointermediate pituitaries in each 
case) were injected (Fig. 1). A Delta-pack Waters 300 A column (3 x 150 mm, 
particle size 5/z) was employed and absorbance was monitored at 214 nm. An 
acetonitrile gradient 9-60% containing 0.05% trifluoroacetic acid was applied 
during 60min. Retention times are indicated in min. Oxytocin-associated 
neurophysin and vasopressin-associated neurophysin are termed VLDV- and 
MSEL-neurophysins, respectively, using the one-letter symbols for amino acids in 
positions 2, 3, 6 and 7 (24). VLDV- and MSEL-neurophysins were identified by 
comparison with pure rat neurophysins (4). 
Assay of Lys-Arg Endopeptidase Activity 
The endoproteolytic a tivity on Z-Ala-Lys-Arg-7 amido-4-methyl-coumarin 
(AMC) (Novabiochem) was determined at final concentration 0.5 mM in 50 mM 
acetate buffer pH 5.0, with and without addition of 2 mM CaCla, as previously 
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Fig. 1. Comparative HPLC of neurosecretory g anule contents 
of heterozygote ( op) and homozygote (bottom) Brattleboro rats 
(Experiment II, Table 2). The arrows how the positions of 
missing vasopressin a d MSEL-neurophysin, respectively, in the 
homozygote Brattleboro rat. 
described (18, 18a). The reaction is linear during at least 4 h. Values without 
addition of CaCI2 were subtracted and fluorescence converted in AMC con- 
centration using a standard curve. One provisional unit of enzymatic activity 
releases one pmol AMC per hour and per ~1 of content or membrane. Activities 
are calculated per mg of wet gland (18). 
RESULTS 
Components of Neurosecretory Granules of Homozygote and Heterozygote 
Brattleboro Rats 
Components of granule contents, particularly neuro-hypophysial hormones 
and their associated neurophysins, were investigated by high-pressure liquid 
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chromatography as shown in Fig. 1. When secretory granules of posterior 
pituitary glands from heterozygote and homozygote Brattleboro rats are com- 
pared by HPLC, it is clear that in the homozygote vasopressin and its associated 
neurophysin, MSEL-neurophysin, are missing (Fig. 1). In contrast oxytocin and 
its associated neurophysin, VLDV-neurophysin, are present. It appears that 
prooxytocin is expressed and processed normally in the homozygote Brattleboro 
rat whereas provasopressin is not. An unprocessed "pathological" provasopressin 
has not been detected in this HPLC experiment but all the peaks were not 
systematically investigated. 
Lys-Arg Endopeptidase Activity in the Anterior and Posterior Pituitary of the 
Wistar Rat 
Secretory granules of neuroendocrine c lls are known to possess two types of 
processing endopeptidases, one with a major specificity for the Lys-Arg 
sequence, the other displaying a preference for the Arg-Arg sequence (17, 18). In 
rat neurohypophysial secretory granules, Lys-Arg endoproteolytic a tivity has 
been shown to be largely predominant (18). Lys-Arg endopeptidase activities 
were measured on the fluorogenic substrate Z-Ala-Lys-Arg-AMC (Novabi- 
oclaem) as previously described. Table 1 gives the dibasic proteolytic activities 
measured on posterior and anterior pituitary lobes of Wistar rats. Four batches 
have been used. Whereas there are variations from batch to batch, it appears that 
the neurointermediate lobe is much richer in dibasic endopeptidase than the 
anterior lobe when activities are calculated per mg/gland. Of the various cell 
types found in the anterior pituitary gland, only corticotrope cells are known to 
use dibasic endopeptidases for processing proopiomelanocortin (22). 
Table 1. CaZ+-dependent dibasic proteolytic ac- 
tivities in the posterior and anterior pituitaries of the 
Wistar Rat (expressed in U/mg gland) 
Membrane Content Total 
Posterior 
1(10" - -  3.2:t:0.3 
2(10) 6.0:t:0.4 3.9+0.6 9.6+1.0 
3(12) 4.9+0.2 5.2+0.1 10.1+0.3 
4(9) 2.7• 2.7 • 5.4+0.9 
Anterior 
1(10) 0.26:1:0.04 0.08+0.06 0.34+0.11 
2(10) 0.175:0.06 0.315:0.12 0.485:0.18 
3 (12) 0.40 5:0.01 0.48 5:0.03 0.88 5:0.04 
Numbers of animals used for the four batches are 
indicated in parentheses. 
Activities are measured in triplicate on Z-A la-Lys-  
Arg-AMC (0.5 mM) in a 50 mM sodium acetate buffer 
pH5.0 containing 1 mM EDTA with and without 
addition of 2mM CaCI2, the latter values being 
subtracted. 
Membrane lost. 
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Compar ison  of dibasic endopept idase  activit ies in heterozygote and homozygote  
Brat t leboro rat  p i tu i tar ies (expressed in U /mg gland) 
Homozygote I a Heterozygote I" Homozygote II Heterozygote n Homozygote In  
(36) (36) (9 = 5 9 + 46) (99) (6 = 3 9 + 36) 
Posterior 
Membrane - -  - -  3.2 + 0.5 5.5 i 0.8 1.0 + 0.1 
Content - -  - -  0.4 + 0.2 1.6 • 0.9 0.5 + 0.1 
Total 1.8 i 0.7 3.0 4- 0.6 3.6 • 0.7 7.1 • 1.7 1.5 • 0.2 
Anterior 
Membrane - -  - -  0.93 • 0.25 0.25 • 0.12 0.26 • 0.04 
Content - -  - -  0.08 • 0.05 0.05 • 0.06 0.12 • 0.03 
Total 0.46 + 0.03 0.66 • 0.16 1.01 • 0.30 0.30 • 0.18 0.38 • 0.07 
Numbers  of rats used in each exper iment  are indicated in parentheses.  
In exper iments  I and I I ,  heterozygotes  and homozygotes  were from the same breeding.  
a In this exper iment ,  membrane  and content  were not separated.  Measures  made after 16 h 
incubation. 
Lys-Arg Endopeptidase Activity in Homozygote and Heterozygote Brattleboro 
Rats 
Table 2 shows the comparison between posterior pituitary glands of 
homozygote and heterozygote Brattleboro rats. The amounts of activities found 
in the posterior and anterior pituitaries of the heterozygote Brattleboro rats are in 
the range of those found for the Wistar rats (6-10 U/mg gland for the posterior 
lobe and 0.3-0.9 U/mg gland for the anterior lobe). A significant decrease of 
dibasic endoproteolytic activity can be noted in the case of posterior lobes of 
homozygote Brattleboro rats when compared with values found for the hetero- 
zygote Brattleboro rats or Wistar rats (1.5-3.6 U/mg gland instead of 6-10 U/mg 
gland. This difference is not observed in the anterior lobe (0.4-1 U/mg gland 
instead of 0.3-0.8 U/mg gland). 
It is clear that in the homozygote Brattleboro rat there is a significant 
decrease of the Lys-Arg endoproteolytic a tivity, routhly about 50% (Tables 1 
and 2). This decrease could not be explained by a reduced biosynthesis n both 
vasopressinergic and oxytocinergic neurons since the processing of prooxytocin 
that involves the Lys-Arg sequence is normal. On the other hand the Lys-Arg 
endoproteolytic a tivity is not modified in the cells of the anterior pituitary gland 
of the homozygote Brattleboro rat. A more acceptable explanation would be that 
hypothalamic vasopressinergic neurons either lack the Lys-Arg endopeptidase or 
the amount is reduced at a level insufficient for processing the precursor. The 
defect should be at the cell-specific gene expression of the enzyme rather than in 
the gene itself. This expression would be normal in the solitary neurons as well as 
in the ovary and adrenal ceils. The occurrence of a peculiar endopeptidase 
inhibitor or the lack of an essential cofactor could also explain but less plausibly 
the decrease of Lys-Arg endoproteolytic a tivity. 
Mammalian furin (22) and amphibian furin (23) cleave proproteins following 
the consensus equence Arg-X-(Lys/Arg)-Arg. Furin would be localized in the 
Golgi apparatus (22) and involved within the constitutive secretory pathway (23). 
In contrast he simple "dibasic" endo-peptidases are found in neuroendocrine 
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cells submitted to regulated secretion and mainly localized in secretory granules 
whose pH corresponds to their pH optimum (17, 18). It is possible that these 
latter enzymes exhibit more subtle substrate specificities that are not apparent 
from mere examination of the cleavage site. It remains to clarify the respective 
implications of the processing endo-peptidase deficiency and the vasopressin 
precursor defect in the lack of vasopressin homozygote Brattleboro rat. 
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